leveraging polyclonal antibody sequencing in therapeutics development pipelines
Published 3 years ago • 1.5K plays • Length 40:33Download video MP4
Download video MP3
Similar videos
-
54:05
leveraging polyclonal antibody sequencing to get high affinity binders against tough targets
-
21:45
landing on the moon with mass spectrometry: polyclonal sequencing with only proteomics
-
13:03
leveraging recombinant patient antibodies in therapeutic applications
-
28:23
antibody protein sequencing: advancing and safeguarding discovery - rapid novor
-
30:46
enriching engineered t-cells with antibody sequencing & modulation
-
38:23
fully harnessing the power of immunotherapy through protein sequencing
-
1:04
how to sequence antibody proteins using mass spec?
-
1:56
remab™ antibody sequencing service report
-
42:34
leveraging the power of next generation protein sequencing to shape tomorrow’s in vitro diagnostics
-
28:04
antibody sequencing as a tool to improve reproducibility in the life sciences
-
36:44
dna vs next gen protein sequencing - a deep dive
-
27:51
antibody sequencing as a tool to improve reproducibility in the life sciences
-
2:45
who is rapid novor?
-
1:18:15
rational antibody design and engineering with next generation protein sequencing
-
24:28
antibody characterization by mass spectrometry
-
45:39
next generation vaccine development with proteomics
-
22:53
why is sequence blindness acceptable with antibodies?
-
1:20
dna sequencing vs. protein sequencing